Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00067704 · ClinicalTrials.gov registry record · NA

Emotional Disclosure in HIV

A NA study, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
283
Enrollment target

NCT00067704 is a NA study that has completed, run by University of Miami. The registered enrollment target is 283 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00067704, a NA study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
283 participants
Enrollment target

Study Summary

The specific objective of this study are to examine whether or not a treatment aimed at emotional disclosure may have beneficial psychological, health and immune effects for HIV infected individuals. The goal of the current study is to test the efficacy of emotional disclosure through writing in patients with HIV infection. We will compare emotional disclosure through writing about traumatic experiences (experimental intervention) to a control intervention (writing about emotionally neutral topics). \[Note that HIV RNA viral load, CD4 T cells, urinary cortisol, health related dysfunction, psychological distress, and medication adherence are the 6 primary outcome variables.

Interventions

  • BEHAVIORAL Trauma writing
  • BEHAVIORAL Writing about daily events

Trial Details

FieldValue
Enrollment Target 283 participants
Start Date 2004-02
Est. Completion 2012-11
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT00067704

The ClinicalTrials.gov registry entry for NCT00067704 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 283 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Trauma writing is the first listed.

NCT00067704 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00067704 about?

NCT00067704 is a clinical study titled "Emotional Disclosure in HIV". The specific objective of this study are to examine whether or not a treatment aimed at emotional disclosure may have beneficial psychological, health and immune effects for HIV infected individuals. The goal of the current study is to test the efficacy of emotional disclosure through writing in pat...

What is the current status of trial NCT00067704?

This trial is currently completed. It is a NA study. The enrollment target is 283 participants. The study started on 2004-02. Estimated completion is 2012-11.

What interventions are being tested in trial NCT00067704?

The interventions under investigation include: Trauma writing (BEHAVIORAL), Writing about daily events (BEHAVIORAL).

Who is sponsoring clinical trial NCT00067704?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.